168 filings
Page 4 of 9
6-K
bkyy0f
5 Jun 20
Aphria Inc. to Present at the Stifel 2020 Virtual Cross Sector Insight Conference
4:07pm
6-K
kzsmofe s42jbymr
27 May 20
Material Change Report
12:00am
6-K
khf6gm12t yn
26 May 20
Aphria Inc. Announces Move to Nasdaq
8:24am
6-K
37xyvey
18 May 20
Material Change Report
12:00am
6-K
ssxder0od r3
14 May 20
Aphria strengthens balance sheet with negotiated debt reduction
2:58pm
6-K
su80de01ykjg1
6 May 20
Aphria Inc. Announces Receipt of EU GMP Certification for Subsidiary ASG Pharma Ltd. and Liquidation of Promissory Note
12:50pm
6-K
h1k17fwbau
17 Apr 20
Aphria Inc. Announces Net Cannabis Revenue Increases 65% From Prior Quarter and Fourth Consecutive Quarter of Positive Adjusted EBITDA
12:00am
6-K
ds71dc52o oy
14 Apr 20
Condensed Interim Consolidated Financial Statements
9:08pm
6-K
drki5bg51yi 8de3
14 Apr 20
Current report (foreign)
3:58pm
6-K
b12pwc6kubp9vc0v8r1p
27 Mar 20
Aphria Inc. Recognized for Executive Gender Diversity by Globe and Mail's Women Lead Here Benchmark and Provides an Update on COVID-19
12:58pm
RW
3pt 0vma9yhsa
27 Mar 20
Registration withdrawal request
6:31am
F-3
jiwajcrq jbez
3 Mar 20
Shelf registration (foreign)
6:04am
6-K
8gzabag
3 Feb 20
Securities Purchase Agreement
4:30pm
SUPPL
gvlsna1akhp ijgy96di
31 Jan 20
Supplemental materials (foreign)
4:30pm
6-K
y7hqe7uz56adsln
31 Jan 20
Aphria Inc. Announces Closing of $100 Million Strategic Investment from Institutional Investor
10:57am
6-K
2aejlr ao7a34t6wq
24 Jan 20
Aphria Inc. Enters Into Agreement to Receive $100 Million Strategic Investment from Institutional Investor
10:01am
6-K
lebmyke8re0 v5m
22 Jan 20
Aphria Inc. Receives EU GMP Certification for Aphria One Facility
9:32am
6-K
ofph9yq3cc04gs3d
22 Jan 20
Aphria Inc. Receives EU GMP Certification for Subsidiary ARA-Avanti Rx Analytics
9:31am
6-K
e6ugc06tulwvjjor5q6
16 Jan 20
Aphria Inc. Launches Plant Positivity Immersive Winter Garden to Help Combat Winter Blues
8:24am
6-K
x1xf jqskxbo4hsw
14 Jan 20
Aphria Inc. Announces Third Consecutive Quarter of Positive Adjusted EBITDA and a 46% Increase in Adult-Use Cannabis Revenue From Prior Quarter
1:17pm